Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a glossary and related topic links (Melanoma and MedlinePlus Genetics) and updated revision metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). Removed older QC labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the prior revision version (v3.3.4).
    Difference
    0.4%
    Check dated 2026-01-28T21:53:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 in the footer. Removed Melanoma and the related topic MedlinePlus Genetics, and removed Revision: v3.3.3 from the related topics.
    Difference
    0.2%
    Check dated 2026-01-14T04:17:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics to the page.
    Difference
    0.2%
    Check dated 2026-01-07T02:17:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a Locations section with state listings (Alabama, Florida, Illinois, Indiana, Virginia). Updated the page revision to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T22:31:53.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now includes a related topics section with Melanoma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2025-12-16T21:42:03.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Removed Melanoma and related MeSH topic links from the More Information/Related Topics section; these are supplementary navigation items. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T19:29:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.